A New Weapon in the Battle Against Cancer

A New Weapon in the Battle Against Cancer »

A new Cambridge-based company hopes to leverage the body's inter-cellular deliver system for cancer diagnosis and treatment.

Happening Now on NEJM Group Open Forum

Happening Now on NEJM Group Open Forum »

12 Jun, 2015
Uncategorized
Written in partnership with Medstro Join the online discussion happening now at NEJM Group Open Forum on Medstro, where New England Journal of Medicine authors answer your questions and discuss their research. Happening Now "NEJM CareerCenter Conversations: Giving Back, Working with Underserved Communities" Working with the underserved presents its unique set of challenges and rewards but may not be an…
Happening Now on NEJM Group Open Forum

Happening Now on NEJM Group Open Forum »

5 Jun, 2015
Uncategorized
Written in partnership with Medstro Join the online discussion happening now at NEJM Group Open Forum on Medstro, where New England Journal of Medicine authors answer your questions and discuss their research. Happening Now "NEJM CareerCenter Conversations: Giving Back, Working with Underserved Communities" Working with the underserved presents its unique set of challenges and rewards but may not be an…
Happening Now on NEJM Group Open Forum

Happening Now on NEJM Group Open Forum »

29 May, 2015
Uncategorized
Written in partnership with Medstro Join the online discussion happening now at NEJM Group Open Forum on Medstro, where New England Journal of Medicine authors answer your questions and discuss their research. Happening Now @NEJM Ask the Author & Experts: ClinGen — The Clinical Genome Resource Dr. Heidi Rehm, Clinical Director, Clinical Research Sequencing Platform at…
Liquid Biopsies Could Make Cancer a Manageable Disease

Liquid Biopsies Could Make Cancer a Manageable Disease »

1 May, 2015
NewsUncategorized
Could a simple blood test revolutionize cancer detection and treatment? Photo via Shawn Hempel/ Shutterstock. The future of cancer treatment is here. A new technology in cancer detection and monitoring called the liquid biopsy (or circulating tumor cell (CTC) count) can detect tumor DNA circulating in the blood before symptoms even…
Wellframe: The Data Dream Team Changing Chronic Disease Management

Wellframe: The Data Dream Team Changing Chronic Disease Management »

24 Jul, 2014
Companies
Wellframe founding members are from left to right: Dr. Jacob Sattelmair, Chief Executive Officer; Archit Bhise, Chief Product Officer; Dr. Trishan Panch, Chief Medical Officer; Vinnie Ramesh, Chief Technology Officer. All images courtesy of Wellframe. Scene 1: Meeting Mrs. Black Could Mrs. Black’s admission have been prevented? The charcoal drawing hanging…

Send this to a friend